Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.

Martín R, Cordova C, San Román JA, Gutierrez B, Cachofeiro V, Nieto ML.

J Mol Cell Cardiol. 2014 Jul;72:250-62. doi: 10.1016/j.yjmcc.2014.04.002.

PMID:
24732212
2.

Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.

Lee JH, Kim TH, Park HE, Lee EG, Jung NC, Song JY, Seo HG, Seung KB, Chang K, Lim DS.

Cardiovasc Res. 2014 Feb 1;101(2):203-10. doi: 10.1093/cvr/cvt246.

3.

Beneficial effects of dimethyl fumarate on experimental autoimmune myocarditis.

Milenković M, Arsenović-Ranin N, Vucićević D, Bufan B, Jancić I, Stojić-Vukanić Z.

Arch Med Res. 2008 Oct;39(7):639-46. doi: 10.1016/j.arcmed.2008.07.003.

PMID:
18760191
4.
5.

Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.

Watanabe K, Sukumaran V, Veeraveedu PT, Thandavarayan RA, Gurusamy N, Ma M, Arozal W, Sari FR, Lakshmanan AP, Arumugam S, Soetikno V, Rajavel V, Suzuki K.

Inflamm Allergy Drug Targets. 2011 Jun;10(3):218-25. Review.

PMID:
21495969
6.

Resveratrol ameliorates experimental autoimmune myocarditis.

Yoshida Y, Shioi T, Izumi T.

Circ J. 2007 Mar;71(3):397-404.

7.

Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice.

Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan MK, Son A, Ishii Y, Kishimoto C, Yodoi J.

Circulation. 2004 Sep 7;110(10):1276-83.

8.

Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.

Zhang S, Liu X, Sun C, Yang J, Wang L, Liu J, Gong L, Jing Y.

Inflammation. 2016 Apr;39(2):678-86. doi: 10.1007/s10753-015-0294-y.

PMID:
26658748
9.

Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.

Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U.

Circ Res. 2009 Aug 28;105(5):462-70. doi: 10.1161/CIRCRESAHA.109.196287.

10.

Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.

Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Lüscher TF, Eriksson U.

Circ Res. 2009 Oct 23;105(9):912-20. doi: 10.1161/CIRCRESAHA.109.199802.

11.

Endothelin receptor antagonist exacerbates autoimmune myocarditis in mice.

Tajiri K, Sakai S, Kimura T, Machino-Ohtsuka T, Murakoshi N, Xu D, Wang Z, Sato A, Miyauchi T, Aonuma K.

Life Sci. 2014 Nov 24;118(2):288-96. doi: 10.1016/j.lfs.2014.01.007.

12.

GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.

Blyszczuk P, Behnke S, Lüscher TF, Eriksson U, Kania G.

Biochim Biophys Acta. 2013 Apr;1833(4):934-44. doi: 10.1016/j.bbamcr.2012.10.008.

13.

Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.

Yuan Z, Nimata M, Okabe TA, Shioji K, Hasegawa K, Kita T, Kishimoto C.

Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1147-52.

14.

Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis.

Liu X, Li B, Wang W, Zhang C, Zhang M, Zhang Y, Xia Y, Dong Z, Guo Y, An F.

Cardiovasc Drugs Ther. 2012 Apr;26(2):121-30. doi: 10.1007/s10557-012-6372-6.

PMID:
22382902
15.

IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway.

Liu Y, Zhu H, Su Z, Sun C, Yin J, Yuan H, Sandoghchian S, Jiao Z, Wang S, Xu H.

Int Immunol. 2012 Oct;24(10):605-12.

16.

Quercetin offers cardioprotection against progression of experimental autoimmune myocarditis by suppression of oxidative and endoplasmic reticulum stress via endothelin-1/MAPK signalling.

Arumugam S, Thandavarayan RA, Arozal W, Sari FR, Giridharan VV, Soetikno V, Palaniyandi SS, Harima M, Suzuki K, Nagata M, Tagaki R, Kodama M, Watanabe K.

Free Radic Res. 2012 Feb;46(2):154-63. doi: 10.3109/10715762.2011.647010.

PMID:
22145946
17.

Rapamycin ameliorates experimental autoimmune myocarditis.

Maeda K, Shioi T, Kosugi R, Yoshida Y, Takahashi K, Machida Y, Izumi T.

Int Heart J. 2005 May;46(3):513-30.

18.

Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats.

Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, Izumi T, Aizawa Y, Seki S, Abo T.

Circ Res. 1998 Jun 1;82(10):1035-42.

19.

Treatment and prevention of experimental autoimmune myocarditis with CD28 superagonists.

Wang S, Liu J, Wang M, Zhang J, Wang Z.

Cardiology. 2010;115(2):107-13. doi: 10.1159/000256660.

PMID:
19907173
20.

T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17.

Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U.

J Exp Med. 2006 Aug 7;203(8):2009-19.

Items per page

Supplemental Content

Support Center